• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Increased Risk of Transfusion Reactions in Postpartum Blood Transfusions

August 28, 2019

Transfusion reactions occur in 0.15% to 3.7% of all transfusions and can range from mild fevers to severe, life-threatening reactions. Since pregnancy is associated with changes in the immune system, researchers in Sweden sought to determine whether transfusion reactions are more common in postpartum blood transfusions. Based on data from the Swedish National Birth Registry, which is linked to the Stockholm Transfusion Database, 517,854 pregnant women were identified of which 2.4% (12,183) received a blood transfusion postpartum. Ninety-six transfusion reactions occurred in the study cohort (79 per 10,000 pregnant women), which was higher compared to non-pregnant women of similar ages who received blood transfusions in Sweden (40 per 10,000 non-pregnant women) (odds ratio, 2.0; 95% CI, 1.6-2.5). Preeclampsia, induction of labor, or a premature delivery are associated with increased risk for a transfusion reaction. These findings underscore the need to carefully monitor postpartum women for transfusion reactions.

Reference: Thurn L, Wikman A, Westgren M and PG Lindqvist. Incidence and risk factors of transfusion reactions in postpartum blood transfusions. Blood Advances 2019; 3(15); 2298-2306.

Filed Under

  • Adverse Events (non-infectious)
  • News
  • Special Transfusion Situations

Recommended

  • Minimal Residual Risk for HIV, Hepatitis B, and Hepatitis C from Blood Products

  • Recombinant ADAMTS13 Treatment for Congenital Thrombotic Thrombocytopenic Purpura

  • Model Predicts Convalescent Plasma Transfusions Will Save Ebola Patient Lives

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • RBC Transfusions in Neonatal ICUs Above Restrictive Hb Thresholds

  • Locally Transmitted Malaria in the United States

  • Global Platelet Transfusion Practices for Patients in the ICU

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley